Primary care clinicians play a vital role in the treatment of patients with epilepsy with ongoing seizures. Advances in anticonvulsant drugs help in the management.

Patients are being sent home from physician offices and emergency departments in the early stages of transverse myelitis, only to return later completely paralyzed. Here's what you need to know about it.

Do antidepressants increase suicide risk? What's the best treatment for ADHD? News from the FDA

By covering a spectrum of pain-relief tactics, the chronic pain contract presented in this article surpasses the limited opioid contract traditionally used in the primary care setting and gives credence to nonopioid treatments.

Primary and secondary stroke can be prevented by the appropriate use of antithrombotic, lipid lowering, and antihypertensive agents. Taken along with the benefits of lifestyle modifications, the cumulative risk reduction is impressive. Prevention is essential because acute treatment options are limited.

When a patient presents with acute neurologic symptoms, what diagnostic studies need your immediate attention? What is the patient's short-term stroke risk? These experts outline a rational approach to this often underestimated emergency.

Stroke treatment update 2007 A crucial decision in the setting of acute ischemic stroke is the determination of which patients are candidates for t-PA. A noted neurologist discusses the benefits and risks while addressing other important aspects of stroke management for primary care physicians. Mar 1, 2007 By: ROGER E. KELLEY, MD

A crucial decision in the setting of acute ischemic stroke is the determination of which patients are candidates for t-PA. A noted neurologist discusses the benefits and risks while addressing other important aspects of stroke management for primary care physicians.

The purpose of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) clinical trial was to assess the effectiveness of various sequential treatment options in patients with nonpsychotic major depressive disorder (MDD) who do not achieve remission on the selective serotonin reuptake inhibitor (SSRI) citalopram.1 The primary end point of this large (4000 subjects aged 18-75), multicenter trial was symptomatic remission—not merely symptomatic response (typically defined as a greater than 50% decrease in symptoms).

ADHD in adults: Primary care management Attention-deficit/hyperactivity disorder in adults—a highly prevalent condition that can have a negative impact on all aspects of a person's life—can be identified and treated in primary care. Here is the information you need on which patients would benefit from screening, how to make the diagnosis, and how to manage the drug regimen. Jan 1, 2007 By: Michelle Khurana, MD, MPH, Howard Schubiner, MD

Attention-deficit/hyperactivity disorder in adults—a highly prevalent condition that can have a negative impact on all aspects of a person's life—can be identified and treated in primary care. Here is the information you need on which patients would benefit from screening, how to make the diagnosis, and how to manage the drug regimen.